L’adaptation des cellules à leur environnement externe repose sur la transduction adéquate de signaux régulés par une pléthore d'événements moléculaires. Parmi ces événements moléculaires, les modifications post-traductionnelles (MPT) de protéines aident à intégrer, à traduire et à organiser de façon spatiotemporelle ces signaux pour que les cellules puissent réagir aux stimuli externes. Parmi les modifications post-traductionnelles, les petites protéines de la famille de l’Ubiquitine (Ublps, Ubiquitin-like proteins) jouent un rôle majeur dans presque toutes les voies de signalisation. Cette thèse rapporte des études fonctionnelles et structurales des interactions covalentes et non covalentes entre SUMO (Small Ubiquitin related MOdifier), un membre de la famille des Ublps, et trois protéines d'échafaudage, TIF1beta, le corépresseur universel des protéines KRAB-multidoigt de zinc, PIAS1, une ligase E3 pour SUMO et PML, un suppresseur de tumeur. La première étude rapporte l'identification et la caractérisation biochimique des sites de SUMOylation de TIF1beta. Nous avons déterminé que la modification covalente de six résidus lysine par SUMO est essentielle à l’activité de répression de la transcription induit par TIF1beta. En outre, nous présentons des évidences indiquant que la SUMOylation de TIF1 exige non seulement sa capacité à homo-oligomériser, mais est aussi positivement régulée par son interaction avec le domaine KRAB des protéines à doigts de zinc. Partant de ce constat, nous postulons que les protéines KRAB-multidoigt de zinc recrutent leur corépresseur TIF1betaà des gènes cibles, mais aussi accentuent son activité répressive grâce à l'augmentation de sa SUMOylation. Notre seconde étude révèle qu’en plus de réprimer la transcription en tant que MPT covalente, SUMO joue aussi un rôle important dans la répression en tant que partenaire non covalent d’interactions protéine-protéine. Nous avons montré que SUMO interagit simultanément avec deux enzymes de la machinerie de SUMOylation, l’unique enzyme de conjugaison E2, UBC9, et la ligase E3 PIAS1 au sein d’un complexe ternaire répresseur. En outre, nous révélons que la formation du complexe ternaire PIAS1:SUMO:UBC9 est modulée par le niveau de phosphorylation de résidus sérine juxtaposés à un motif d’interaction avec SUMO (SIM) dans PIAS1. Ainsi, SUMO agit comme un adaptateur spécifique qui stabilise les interactions UBC9 E2: E3 PIAS1. Partant de ce constat, nous proposons que les enzymes E2 et E3 des autres systèmes Ublps exploitent des mécanismes similaires dans le cadre de leur fonction Enfin, notre troisième étude explore la régulation des interactions non covalentes de SUMO par la phosphorylation. En utilisant une combinaison d'études in vivo et in vitro, nous démontrons que l'interaction entre SUMO1 et PML est régi par la phosphorylation dépendant de CK2 sur quatre résidus sérine de PML. Les structures cristallographiques des complexes PML-SIM:SUMO1 révèlent que les phospho-sérines de PML contactent des résidus de la région basique de SUMO1. Sachant que la kinase CK2 peut être induite par des kinases activables par le stress, ces résultats suggèrent que les interactions non-covalentes avec SUMO sont modulées par le stress cellulaire. Sur la base de cette constatation, nous postulons que des événements analogues affectent des protéines contenant des séquences SIM ciblées par CK2. En résumé, cette étude révèle qu’en plus de son rôle de MPT, SUMO peut fonctionner comme un adaptateur permettant des interactions spécifiques entre protéines tel que pour les enzymes E3 et E2. / Cell adaption to the external environment relies on proper signal transduction that is orchestrated by a plethora of molecular events. Among these molecular events, post-translational modifications (PTMs) of proteins help to spatiotemporally integrate, translate and dispatch signals so cells can respond to external stimuli. Among these post-translational modifications, the Ubiquitin-like proteins (Ublps) play a major role in almost all signaling pathways. This thesis reports functional and structural studies of the covalent and non-covalent interactions between the Small Ubiquitin-related MOdifier (SUMO), a member of the Ublps family, and three scaffold proteins, TIF1beta, the corepressor of KRAB-Multifinger proteins, PIAS1, a SUMO E3 ligase and the Promyleocytic leukemia (PML) tumor suppressor protein. The first study reports the identification and the biochemical characterization of TIF1betaSUMOylation sites. We mapped six SUMOylation sites in TIF1beta and determined that the covalent modification of these sites by SUMO is essential for its transcriptional repression activity. In addition, we present evidence indicating that SUMOylation of TIF1beta requires not only its ability to homo-oligomerize, but is positively regulated through its interaction with KRAB domains found in zinc-finger proteins. Based on this finding, we postulate that these KRAB domain containing multifinger proteins not only recruit TIF1beta co-repressor to target genes but also increase its repressive activity through enhancement of its SUMOylation. The work in the second study reveals that in addition to suppressing transcription as a covalent PTM, SUMO plays an important role in repression as a non-covalent protein-protein interaction partner. We determine that SUMO can form a repressive complex by simultaneously forming non-covalent interactions with UBC9 and PIAS1, the E2 and E3 enzymes in the SUMOylation system. In addition, we report that the formation of the PIAS1:SUMO:UBC9 ternary complex is modulated by the phosphorylation of serine residues juxtaposed to a SUMO-Interacting Motif (SIM) found in PIAS1. Thus SUMO acts as a specific adaptor that stabilizes UBC9 E2: PIAS1 E3 interactions. Based on this finding, we propose that the E2 and E3 enzymes from other Ublps systems exploit similar mechanisms as part of their function Finally, our third study explores the regulation of SUMO non-covalent interactions by phosphorylation. Using a combination of in vivo and in vitro studies we demonstrate that the interaction between SUMO1 and PML is governed by CK2-dependent phosphorylation of four serine residues in PML. Crystal structures of PML-SIM:SUMO1 complexes reveal that these PML phospho-serine specifically contact SUMO1 basic patch residues. Since CK2 kinase is induced by stress activated kinases pathways, this indicates that SUMO non-covalent interactions are regulated by cellular stress. Based on this finding, we postulated that analogous events influence other CK2-targeted SIM-containing proteins. In summary, this study reveals that in addition to its well described function as PTM, SUMO can function as an adaptor enabling specific proteins interactions such as functional E3:E2 enzymes pairs.

T-lymphocytes are an essential cell type of the adaptive immune system. Due to their importance in immune responses and disorders, the molecular mechanisms leading to T-lymphocyte activation have been the subject of extensive research which has translated into important therapeutic developments. Early signalling events involving tyrosine phosphorylation are well characterised. However, later events involving other post-translational modifications are less well understood. Several studies have provided evidence suggesting a role for protein arginine methylation in T-lymphocyte activation. Arginine methylation is an essential post-translational modification in mammals and yet has not been extensively studied. No large scale analysis of arginine methylation sites has been performed. To gain insight into the role of protein arginine methylation in T-lymphocyte activation, the aims of this work were to: 1. Establish whether levels of arginine methylation are altered during Tlymphocyte activation 2. Use mass spectrometry based proteomics to identify arginine methylated proteins in the T-lymphocyte proteome 3. Further characterise an arginine methylated protein important to Tlymphocyte activation Arginine methylation was found to be induced after long term (>20 hours) stimulation of primary T-lymphocytes. Large increases in the main protein arginine methyltransferase, PRMT1, were also observed. Enrichment and labelling methods were developed to detect arginine methylated peptides from T-lymphocytes by mass spectrometry. This resulted in the identification of 265 unique arginine methylation sites in 141 proteins. 204 of the methylation sites were novel and 103 of the proteins had not previously been described as arginine methylated. Individual arginine methylation sites were characterised before and after activation of T-lymphocytes, with some sites showing significant changes in abundance. Among the novel arginine methylated proteins discovered were Dynamin II, WASp and WIPF1. These proteins are involved in re-organisation of the actin cytoskeleton at the immunological synapse formed between a Tlymphocyte and an antigen presenting cell. The functional consequences of the arginine methylation sites inWASp were characterised. WASp is essential for T-lymphocyte activation and some initial evidence showed that one of the arginine methylation sites is important for WASp activation.

Les histones sont des protéines nucléaires hautement conservées chez les cellules des eucaryotes. Elles permettent d’organiser et de compacter l’ADN sous la forme de nucléosomes, ceux-ci representant les sous unités de base de la chromatine. Les histones peuvent être modifiées par de nombreuses modifications post-traductionnelles (PTMs) telles que l’acétylation, la méthylation et la phosphorylation. Ces modifications jouent un rôle essentiel dans la réplication de l’ADN, la transcription et l’assemblage de la chromatine. L’abondance de ces modifications peut varier de facon significative lors du developpement des maladies incluant plusieurs types de cancer. Par exemple, la perte totale de la triméthylation sur H4K20 ainsi que l’acétylation sur H4K16 sont des marqueurs tumoraux spécifiques a certains types de cancer chez l’humain. Par conséquent, l’étude de ces modifications et des événements determinant la dynamique des leurs changements d’abondance sont des atouts importants pour mieux comprendre les fonctions cellulaires et moléculaires lors du développement de la maladie. De manière générale, les modifications des histones sont étudiées par des approches biochimiques telles que les immuno-buvardage de type Western ou les méthodes d’immunoprécipitation de la chromatine (ChIP). Cependant, ces approches présentent plusieurs inconvénients telles que le manque de spécificité ou la disponibilité des anticorps, leur coût ou encore la difficulté de les produire et de les valider. Au cours des dernières décennies, la spectrométrie de masse (MS) s’est avérée être une méthode performante pour la caractérisation et la quantification des modifications d’histones. La MS offre de nombreux avantages par rapport aux techniques traditionnelles. Entre autre, elle permet d’effectuer des analyses reproductibles, spécifiques et facilite l’etude d’un large spectre de PTMs en une seule analyse. Dans cette thèse, nous présenterons le développement et l’application de nouveaux outils analytiques pour l’identification et à la quantification des PTMs modifiant les histones. Dans un premier temps, une méthode a été développée pour mesurer les changements d’acétylation spécifiques à certains sites des histones. Cette méthode combine l’analyse des histones intactes et les méthodes de séquençage peptidique afin de déterminer les changements d’acétylation suite à la réaction in vitro par l’histone acétyltransférase (HAT) de levure Rtt109 en présence de ses chaperonnes (Asf1 ou Vps75). Dans un second temps, nous avons développé une méthode d’analyse des peptides isomériques des histones. Cette méthode combine la LC-MS/MS à haute résolution et un nouvel outil informatique appelé Iso-PeptidAce qui permet de déconvoluer les spectres mixtes de peptides isomériques. Nous avons évalué Iso-PeptidAce avec un mélange de peptides synthétiques isomériques. Nous avons également validé les performances de cette approche avec des histones isolées de cellules humaines érythroleucémiques (K562) traitées avec des inhibiteurs d’histones désacétylases (HDACi) utilisés en clinique, et des histones de Saccharomyces cerevisiae liées au facteur d’assemblage de la chromatine (CAF-1) purifiées par chromatographie d’affinité. Enfin, en utilisant la méthode présentée précédemment, nous avons fait une analyse approfondie de la spécificité de plusieurs HATs et HDACs chez Schizosaccharomyces pombe. Nous avons donc déterminé les niveaux d’acétylation d’histones purifiées à partir de cellules contrôles ou de souches mutantes auxquelles il manque une HAT ou HDAC. Notre analyse nous a permis de valider plusieurs cibles connues des HATs et HDACs et d’en identifier de nouvelles. Nos données ont également permis de définir le rôle des différentes HATs et HDACs dans le maintien de l’équilibre d’acétylation des histones. Dans l’ensemble, nous anticipons que les méthodes décrites dans cette thèse permettront de résoudre certains défis rencontrés dans l’étude de la chromatine. De plus, ces données apportent de nouvelles connaissances pour l’élaboration d’études génétiques et biochimiques utilisant S. pombe. / Histones are highly conserved, basic proteins found in eukaryotic cell nuclei. They organize and package DNA strands into nucleosome core particles (NCPs), the fundamental repeating units of eukaryotic chromatin. The histones are subject to a wide variety of posttranslational modifications (PTMs) including acetylation, methylation and phosphorylation. These PTMs play an essential role in DNA-replication, transcription, and chromatin assembly. Alterations in histone PTM abundances have been implicated in several types of cancer. For example, the global loss of trimethylation at H4K20 and acetylation at H4K16 is a hallmark of human cancers. Thus, characterization of histone PTMs and their dynamics is extremely useful for elucidating normal cellular functions and molecular pathways that lead to diseases. Traditionally, histone PTMs are analyzed using antibody-based approaches such as western blot and chromatin immunoprecipitation (ChIP) assays. These methods, however, suffer from several limitations including antibody cross-reactivity, epitope occlusion, and the cost and difficulty in producing and validating antibodies. Over the last decade, mass spectrometry (MS) has emerged as a powerful technique for the characterization and quantification of histone PTMs. MS offers several advantages over the traditional approaches including reproducibility, specificity, and ability to rapidly analyze numerous PTMs in a single experiment. In this thesis, the development and applications of novel analytical tools for the identification and quantification of histone PTMs are presented. First, a method useful for measuring the global and site specific changes in histone acetylation is described. This method combines intact mass analysis and peptide sequencing approaches to study the global and site specific changes in histone acetylation during in vitro assays with yeast Rtt109 and its chaperone (Asf1 or Vps75). Second, a method for analysis of isomeric histone peptides is presented. This method combines a high resolution LC-MS/MS with a novel bioinformatics tool called Iso-PeptidAce to deconvolute mixed spectra of co-eluting isomeric peptides. We benchmarked Iso-PeptidAce using mixtures of synthetic isomeric peptides. We demonstrated its capability in histones isolated from human erythroleukemic (K562) cells treated with clinically relevant histone deacetylase inhibitors (HDACi) and in affinity-purified S. cerevisiae histones bound to chromatin assembly factor-1 (CAF-1). Third, by employing the above methods, an in-depth quantitative analysis of the substrate specificities of several fission yeast HATs and HDACs was assessed. We determined the acetylation site occupancy of multiple lysines in histones isolated from a control or mutant strains lacking specific HAT or HDAC activities. Our analysis identified several known and novel HAT and HDAC target sites. Our data also defined the division of labor between the different HATs and HDACs in maintaining the steady-state level of histone acetylation. Overall, we anticipate that the methods described in this thesis will address some of the existing challenges facing the chromatin field. Moreover, the data presented will provide valuable insights for future genetic and biochemical studies involving the fission yeast.

Les éléments transposables sont des séquences génomiques capables de se répliquer et de se déplacer dans les génomes. Leur capacité à s’insérer près des gènes et à produire des réarrangements chromosomiques par recombinaison entre copies, font des éléments transposables des agents mutagènes. Les éléments transposables sont de plus capables de modifier l’expression des gènes voisins grâce aux régions promotrices qu’ils possèdent. Les éléments transposables ont été trouvés dans la plupart des génomes dans lesquels ils ont été recherchés. Ils forment ainsi 45 % du génome de l’homme et peuvent représenter jusqu’à 90 % du génome de certaines plantes. Dans la première partie de ma thèse, je me suis penché sur les facteurs qui déterminent la distribution de ces éléments. Je me suis intéressé à un facteur particulier, qui est la fonction des gènes dans le voisinage des insertions d’éléments transposables. Dans la deuxième partie, j’ai essayé de déterminer l’impact de l’altération des modifications épigénétiques (modifications d’histones plus précisément) associées aux différents composants géniques, dont les éléments transposables, sur la variation de l’expression des gènes en condition tumorale. / Transposable elements are genomic sequences able to replicate themselves and to move within genomes. Their ability to integrate near genes and to produce chromosomal rearrangements by recombination between copies, make transposable elements mutagens. Moreover, transposable elements are able to alter the expression of neighboring genes through their promoter regions. Transposable elements form 45% of the human genome and may represent up to 90% of certain plant genomes. In the first part of my thesis, I examined the factors that determine the distribution of these elements. I have been interested in a particular factor, which is the function of the genes in the vicinity of transposable element insertions. In the second part, I determined the impact of epigenetic modifications alterations (histone modifications) in different gene components, including transposable elements, on the variation of gene expression in tumoral conditions.

L'étude des modifications post-traductionnelles a connu au cours des dernières années un regain d'intérêt notable. Tout d'abord car elle s'effectue aujourd'hui au travers d'approches basées sur la spectrométrie de masse, technique qui pendant cette période a connu de profonds bouleversements, conduisant à des études plus aisées et systématiques.Mais aussi car tant par leur variété que par le rôle qu'elles jouent dans la vie et la régulation cellulaire, ces modifications ne peuvent plus être négligées. Par ailleurs au cours de ces quinze dernières années, nous avons assisté concernant les procaryotes à un changement total de paradigme. En effet à la fin des années 90, l'idée dominante était que ces modifications pouvaient exister chez ceux-ci mais de façon très partielle et/ou très particulière.Dans ce travail, les divers degrés d'iodation de la tyrosine ont été sondés par une approche de type «shotgun » sur un organe entier, la thyroïde de souris. L'efficacité de ce type d'approche démontrée, les modifications post-traductionnelles potentiellement présentes dans des organismes modèles radiorésistants, la bactérie Deinococcus deserti et l'archée Thermococcus gammatolerans ont été analysées. Dans le premier cas, les données de protéomique montrent que de nombreuses acétylations N-terminales portent sur un motif spécifique (essentiellement des thréonines et sérines), cas très atypique pour une bactérie. Chez Thermococcus gammatolerans les acétylations N-terminales sont rares, mais la présence d'acétylations sur les chaînes latérales des lysines est notable. La présence de phosphorylations sur ces mêmes protéines, laisse entrevoir un possible phénomène de « cross talk » entre les lysines acétylées et les sérines et/ou thréonines phosphorylées.Ici, nous démontrons que la complexité du protéome chez les procaryotes par le biais des MPT est bien réelle et que de possibles interdépendances entre MPT mériteraient un regard nouveau. / Recently, the study of post-translational modifications has greatly evolved, mainly because of crucial progresses in mass spectrometry methodology which have allowed high-throughput, high resolution analysis. Their variety and their role in the regulation of key molecular mechanisms are increasingly documented. In this work, the different degrees of iodination of tyrosine were probed with a "shotgun" approach carried out from an entire organ, the mice thyroid. Post-translational modifications present in two radioresistant organism models, the bacterium Deinococcus deserti and the archaeon Thermococcus gammatolerans, were analyzed. The large scale exploration of N-terminal acetylation in D. deserti indicates a specific pattern of this modification on serine and threonine, as well as an atypical, high propension to acetylation with 50% of modified N-termini. In T. gammatolerans, N-terminal acetylation is rare, but the presence of acetylation on lysine side chains is significant. The presence of phosphorylation on these proteins suggests a potential "cross talk" between the acetylated lysine and phosphorylated serine or threonine residues. This work demonstrates that the complexity of the proteome in prokaryotes through post-translational modifications is higher than expected when extremophiles are scrutinized compared to classical prokaryote models. Interdependencies between post-translational modifications definitively deserve a fresher look.

Wnt signalling represents an important mechanism participating in control of cellular and developmental processes, including establishment of cell polarity, cell fate specification, stem cell self-renewal, tissue patterning and organogenesis, homeostasis maintenance and regeneration. Misregulation of the Wnt signalling during embryogenesis leads to developmental defects while aberrant activation later in development is associated with degenerative diseases and a number of cancers. The presented PhD thesis is based on four original publications that deal with the post-translational modifications of Wnt ligands and molecular mechanisms contributing to the regulation of a transcriptional profile of the so-called canonical Wnt pathway. Wnt signalling pathway is used repetitively both in time and different cellular contexts throughout development of multicellular organisms. Inevitably, in each single situation -catenin/TCF complexes, the downstream effectors, induce only subsets of all potential target genes. How this differential tissue- and stage-specific control over various subsets of target genes is achieved with such a limited number of nuclear effectors is not fully understood. Along with the expression of specific LEF/TCF family members or their variants containing different functional domains...

La phosphorylation oxydative est un processus majeur du métabolisme énergétique qui est catalysée par les enzymes de la chaîne respiratoire (OXPHOS), localisées dans la membrane interne des mitochondries. Sa dérégulation est souvent associée à des pathologies, par exemple aux maladies mitochondriales et neurodégénératives. La régulation de la phosphorylation oxydative par la phosphorylation reste encore peu comprise et peu étudiée. Pourtant, la phosphorylation est une des modifications post-traductionnelles les plus répandues dans la cellule, régulant de nombreux aspects de la vie cellulaire et dont l’altération est associée à des pathologies au niveau cellulaire (Alzheimer, Parkinson, cancer). Concernant la phosphorylation oxydative, il est à noter que quelques sites de phosphorylation des complexes respiratoires, en particulier du complexe IV, ont été montrés comme ayant un effet sur leur stabilité et/ou leur activité. Toutefois la connaissance du phosphoprotéome mitochondrial n’est pas suffisamment documentée à ce jour pour identifier les différents rôles que pourraient jouer la phosphorylation au niveau de la mitochondrie et en particulier, de la chaîne respiratoire. Dans la première partie de la thèse, nous nous sommes intéressés à l’analyse du phosphoprotéome mitochondrial de Saccharomyces cerevisiae dans trois conditions de culture : respiratoire (YLAC), respiro-fermentaire (YPGalA) et fermentaire (YPGA). Nous avons quantifiés près de 300 sites de phosphorylation dans la mitochondrie, dont 90 ont un niveau de phosphorylation variable selon le substrat. Les données que nous avons obtenues constituent une base pour l’analyse de la phosphorylation mitochondriale et de la compréhension de son mécanisme. Les sites de phosphorylation de la voie métabolique énergie sont ceux présentant le plus de variation de leur niveau de phosphorylation. La localisation des résidus phosphorylés sur la structure des complexes respiratoires nous a permis d’émettre des hypothèses sur le rôle de ces résidus. Afin de normaliser la quantité des résidus phosphorylés dans les trois conditions de culture, nous avons aussi quantifié le protéome mitochondrial dans les trois conditions de culture. Ceci nous a permis d’argumenter en faveur d’un métabolisme respiro-fermentaire en YPGalA, question encore largement discutée à ce jour. Enfin, cette première étude quantitative du protéome et phosphoprotéome mitochondrial constitue une avancée dans l’étude de la régulation de la mitochondrie par la phosphorylation. Elle peut notamment apporter des informations applicables à l’étude du cancer : en effet, les cellules saines ont un métabolisme respiratoire tandis que les cellules tumorales, dérégulées, ont un métabolisme fermentaire. La seconde partie de la thèse concerne l’analyse du rôle de deux sous-unités du complexe IV de la chaîne respiratoire : les sous-unités Cox12p et Cox13p, encore peu étudiées à ce jour. De plus, deux sites de phosphorylation ont été identifiés sur la sous-unité Cox12p. Dans un premier temps, nous nous sommes intéressés au rôle de ces sous-unités, notamment au niveau de l’assemblage et de l’activité du complexe IV, en analysant des mutants Δcox12, Δcox13 et Δcox12Δcox13. Dans un deuxième temps, nous nous sommes intéressés au rôle des deux sites de phosphorylation de Cox12p : Ser7 et ser82. Nous avons généré les mutants phosphomimétiques de ces deux résidus et étudié leurs effets sur la stabilité et/ou l’activité du complexe IV. Cette seconde étude nous a notamment permis d’identifier un rôle de Cox12p sur la stabilité du complexe et un rôle de Cox13p dans sa dimérisation. La phosphorylation de Cox12p au niveau de la Ser7 semble aussi déstabiliser le complexe IV. De plus, la phosphorylation de la Ser7 et de la Ser82 semblent influencer l’interaction du cytochrome c avec le complexe IV. Cette hypothèse reste à vérifier mais est pertinente du fait de la proximité de Cox12p avec Cox2p, qui porte le lieu de fixation du cytochrome c. / Mitochondria are the powerhouses of cells, providing energy in the form of adenosine triphosphate (ATP). The synthesis of ATP is achieved by oxidative phosphorylation (OXPHOS), a process catalyzed by the respiratory chain, which is located in the inner membrane of mitochondria. Deregulation of OXPHOS is often associated to diseases. Deregulation is particularly observed in mitochondrial diseases and neurodegenerative diseases, but regulation of respiration by phosphorylation is still poorly understood.However, phosphorylation is one of the most frequent post-translational modifications in the cell, modulating most processes, and defects at a cellular level are observed in some diseases (Alzheimer, Parkinson, cancer). Moreover, some phosphorylation sites have been identified in the respiratory complexes, particularly in the complex IV; some of them have an effect on the stability and/or activity of the complex, but we still lack a comprehensive study about mitochondrial phosphoproteome. Such analysis would be necessary to extend the role of phosphorylation in the regulation of mitochondrial functions in general, and in the regulation of the respiratory chain in particular.In the first part of this thesis, we focused on the analysis of the mitochondrial phosphoproteome of Saccharomyces cerevisiae. We studied the mitochondrial phosphoproteome in three growth conditions: in the respiratory condition (YLAC), in the fermentable condition (YPGA) and in an intermediate one (YPGalA). We quantified around 300 mitochondrial phosphorylation sites in which 90 displayed a different level of phosphorylation according to the substrate. This study is a first step towards understanding mitochondrial phosphorylation and its mechanism. Phosphorylation sites with varying levels of phosphorylation according to their conditions are mostly located on proteins involved in energy metabolism. We localized the phosphosites on the structure of the respiratory complexes when it was possible. This allowed us to make hypotheses on the role of these residues. In order to normalize the quantity of phosphorylation sites in the three growth conditions, we also studied the mitochondrial proteome in the three conditions. These results helped us to understand the energetic metabolism of galactose, which is surely intermediate between respiration and fementation, a question still debated nowadays.Finally this proteomic and phosphoproteomic study is a step forward in the comprehension of regulation of mitochondria by phosphorylation. These results can be used as a model to study cancer cells because they display a deregulation in the energetic metabolism: normal cells display respiratory metabolism whereas cancer cells exhibit fermentable metabolism.The second part of this thesis was the study of two subunits of complex IV of the respiratory chain: Cox12p and Cox13p, which had been poorly studied. Moreover, two phosphorylation sites had been identified in the subunit Cox12p. First we were interested in the role of these two proteins, thus we compared the mitochondria of mutants Δcox12, Δcox13 et Δcox12Δcox13 with wild-type mitochondria. We particularly focused on the assembly and the activity of complex IV. Secondly, we analyzed the role of the two phosphosites of Cox12p: Ser7 and Ser82. We generated phosphomimetic mutants of these two residues and observed their effects on the stability and/or activity of complex IV.All of these results allowed us to identify a role of Cox12p in the stability of complex IV and a role of Cox13p in the dimerization of complex IV. Phosphorylation of Ser7 of Cox12p seemed to destabilize the complex. Moreover phosphorylation of both Ser7 and Ser82 of Cox12p seemed to modify the interaction between cytochrome c and complex IV; this hypothesis remains to be tested but is relevant according to the proximity between Cox12p and the subunit Cox2p, where the cytochrome c interacts.

The citrulline-nitric oxide (NO) cycle, comprised of the enzymes argininosuccinate synthase (AS), argininosuccinate lyase (AL) and endothelial nitric oxide synthase (eNOS), is responsible for the regulated production of endothelial NO. Although most studies have focused on eNOS to uncover important regulatory mechanisms, we and others have determined that AS is an essential and regulated step in endothelial NO production. AS is rate limiting for endothelial NO production and is the primary source of arginine, the substrate for eNOS-mediated NO production, despite saturating intracellular levels of arginine and available arginine transport systems. AS is essential for endothelial cell viability and its expression is regulated coordinately with eNOS by TNF and thiazolidenediones with concomitant effects on NO production. Given the importance of AS for endothelial health, we explored three independent regulatory mechanisms. In Chapter One, the functional consequences of altered AS expression due to overexpression, insulin, VEGF and ceramide were studied. We demonstrated that overexpression of AS leads to enhanced NO production and that insulin, VEGF and ceramide coordinately regulate the expression of AS and eNOS. In Chapter Two, the first post-translational modifications of AS in the endothelium were characterized. We determined that AS is an endogenous phosphoprotein in the endothelium, described several levels of biological significance of AS phosphorylation, identified 7 sites of AS phosphorylation and began to uncover the direct impact of phosphorylation on AS function. Finally, in Chapter Three, endothelial AS subcellular localization was defined and important protein interactions were identified including caveolin-1 and HSP90. The work presented in this dissertation demonstrates that multiple mechanisms regulate the function of AS, often coordinately with eNOS, and have a direct impact on nitric oxide production. Our findings suggest that the global understanding of the citrulline-NO cycle as a metabolic unit will unravel new paradigms that will re-define our understanding of the regulation of vascular function by NO.

In 2001 the human proteome organization (HUPO) was created with the ambition to identify and characterize all proteins encoded in the human genome according to several criteria; their expression levels in different tissues and under different conditions; the sub-cellular localization; post-translational modifications; interactions, and if possible also the relationship between their structure and function.When the knowledge of different proteins and their potential interactions increases, so does the need for methods able to unravel the nature of molecular processes in cells and organized tissues, and ultimately for clinical use in samples obtained from patients. The in situ proximity ligation assay (in situ PLA) was developed to provide localized detection of proteins, post-translational modifications and protein-protein interactions in fixed cells and tissues. Dual recognition of the target or interacting targets is a prerequisite for the creation of a circular reporter DNA molecule, which subsequently is locally amplified for visualization of individual protein molecules in single cells. These features offer the high sensitivity and selectivity required for detection of even rare target molecules. Herein in situ PLA was first established and then employed as a tool for detection of both interactions and post-translational modifications in cultured cells and tissue samples. In situ PLA was also adapted to high content screening (HCS) for therapeutic effects, where it was applied for cell-based drug screening of inhibitors influencing post-translational modifications. This was performed using primary cells, paving the way for evaluation of drug effects on cells from patient as a diagnostic tool in personalized medicine. In conclusion, this thesis describes the development and applications of in situ PLA as a tool to study proteins, post-translational modifications and protein-protein interactions in genetically unmodified cells and tissues, and for clinical interactomics.

Embryonic stem cells (ESCs) are characterized by their unlimited capacity for self-renewal and the ability to contribute to every lineage of the developing embryo. The promoters of developmentally regulated loci within these cells are marked by coincident epigenetic modifications of gene activation and repression, termed bivalent domains. Trithorax group (TrxG) and Polycomb Group (PcG) proteins respectively place these epigenetic marks on chromatin and extensively colocalize with Oct4 in ESCs. Although it appears that these cells are poised and ready for differentiation, the switch that permits this transition is critically held in check. The derepression of bivalent domains upon knockdown of Oct4 or PcG underscores their respective roles in maintaining the pluripotent state through epigenetic regulation of chromatin structure. The mechanisms that facilitate the recruitment and retention of Oct4, TrxG, and PcG proteins at developmentally regulated loci to maintain the pluripotent state, however, remain unknown. Oct4 may function as either a transcriptional activator or repressor. Prevailing thought holds that both of these activities are required to maintain the pluripotent state through activation of genes implicated in pluripotency and cell-cycle control with concomitant repression of genes required for differentiation and lineage-specific differentiation. More recent evidence however, suggests that the activator function of Oct4 may play a more critical role in maintaining the pluripotent state (Hammachi et al., 2012). The purpose of the studies described in this dissertation was to clarify the underlying mechanisms by which Oct4 functions in transcriptional activation and repression. By so doing, we wished to contextualize its role in pluripotent cells, and to provide insight into how changes in Oct4 function might account for its ability to facilitate cell fate transitions. As a result of our studies we find that Oct4 function is dependent upon post-translational modifications (PTMs). We find through a combination of experimental approaches, including genome-wide microarray analysis, bioinformatics, chromatin immunoprecipitation, functional molecular, and biochemical analyses, that in the pluripotent state Oct4, Akt, and Hmgb2 participate in a regulatory feedback loop. Akt-mediated phosphorylation of Oct4 facilitates interaction with PcG recruiter Hmgb2. Consequently, Hmgb2 functions as a context dependent modulator of Akt and Oct4 function, promoting transcriptional poise at Oct4 bound loci. Sumoylation of Oct4 is then required to maintain Hmgb2 enrichment at repressed loci and to transmit the H3K27me3 mark in daughter progeny. The expression of Oct4 phosphorylation mutants however, leads to Akt inactivation and initiates the DNA Damage Checkpoint response. Our results suggest that this may subsequently facilitate chromatin reorganization and cell fate transitions. In summary, our results suggest that controlled modulation of Oct4, Akt, and Hmgb2 function is required to maintain pluripotency and for the faithful induction of transcriptional programs required for lineage specific differentiation.